Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2190

TDMS Study 05145-01 Pathology Tables



                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                            TRICAPRYLIN


NTP Experiment-Test: 05145-01                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/17/94
Route: GAVAGE                                                                                                     Time: 20:47:57




       Facility:  TSI Mason Research

       Chemical CAS #:  538-23-8

       Lock Date:  12/26/91

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05145-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            TRICAPRYLIN                                        Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 20:47:57  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60           60                                     
  Scheduled Sacrifice                                 10           10           10            7                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                15           13           15           17                                     
    Natural Death                                      4            7            4           13                                     
  Survivors                                                                                                                         
    Moribund Sacrifice                                                           1                                                  
    Terminal Sacrifice                                29           30           30           22                                     
    Natural Death                                      2                                      1                                     
  Animals Examined Microscopically                    60           60           60           60                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (57)         (56)         (58)         (51)                                   
      Ulcer                                                                      1 (2%)                                             
   Intestine Small, Duodenum                          (59)         (56)         (58)         (49)                                   
      Hyperplasia, Adenomatous                         1 (2%)                                                                       
      Ulcer                                                                                   1 (2%)                                
   Intestine Small, Ileum                             (56)         (56)         (58)         (49)                                   
      Inflammation, Acute                              1 (2%)                                                                       
      Ulcer                                            1 (2%)       1 (2%)       1 (2%)                                             
   Liver                                              (60)         (60)         (60)         (58)                                   
      Basophilic Focus                                35 (58%)     39 (65%)     34 (57%)     31 (53%)                               
      Clear Cell Focus                                10 (17%)     20 (33%)     22 (37%)     13 (22%)                               
      Congestion                                                    1 (2%)       2 (3%)                                             
      Cyst                                                                                    1 (2%)                                
      Cyst Multilocular                                                          1 (2%)                                             
      Eosinophilic Focus                               7 (12%)      4 (7%)       6 (10%)      3 (5%)                                
      Fatty Change, Diffuse                            1 (2%)                    2 (3%)                                             
      Fatty Change, Focal                              4 (7%)       2 (3%)                    3 (5%)                                
      Fibrosis                                                                   1 (2%)       1 (2%)                                
      Hepatodiaphragmatic Nodule                       3 (5%)       5 (8%)       7 (12%)      6 (10%)                               
      Hyperplasia                                      1 (2%)       5 (8%)       2 (3%)                                             
      Hypertrophy                                                                             1 (2%)                                
      Infarct                                                                                 1 (2%)                                
      Mixed Cell Focus                                 7 (12%)      7 (12%)      7 (12%)      4 (7%)                                
      Necrosis                                         3 (5%)       2 (3%)       3 (5%)       1 (2%)                                
      Necrosis, Focal                                               1 (2%)                                                          
      Thrombosis                                       1 (2%)                    1 (2%)                                             
      Bile Duct, Hyperplasia                           1 (2%)                                                                       
      Centrilobular, Degeneration                                   1 (2%)                                                          
   Mesentery                                          (9)          (14)         (4)          (6)                                    
      Thrombosis                                                    1 (7%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05145-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            TRICAPRYLIN                                        Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 20:47:57  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Artery, Inflammation, Chronic Active                          1 (7%)                                                          
      Fat, Hemorrhage                                               1 (7%)                                                          
      Fat, Inflammation, Chronic Active                1 (11%)                                1 (17%)                               
      Fat, Mineralization                              1 (11%)      2 (14%)                                                         
      Fat, Necrosis                                    3 (33%)      8 (57%)      1 (25%)      4 (67%)                               
   Pancreas                                           (59)         (59)         (59)         (57)                                   
      Atrophy                                          1 (2%)                                                                       
      Congestion                                                                              1 (2%)                                
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Thrombosis                                                                 2 (3%)                                             
      Acinus, Atrophy                                 37 (63%)     41 (69%)     38 (64%)     29 (51%)                               
      Acinus, Basophilic Focus                         1 (2%)                    1 (2%)                                             
      Acinus, Hyperplasia                             11 (19%)     11 (19%)     24 (41%)     35 (61%)                               
      Artery, Hyperplasia                              2 (3%)       1 (2%)       1 (2%)       3 (5%)                                
      Artery, Inflammation, Chronic Active             2 (3%)       4 (7%)       4 (7%)       2 (4%)                                
      Artery, Mineralization                                                                  1 (2%)                                
   Pharynx                                            (1)          (1)                                                              
      Thrombosis                                       1 (100%)                                                                     
   Salivary Glands                                    (60)         (59)         (58)         (58)                                   
      Cyst                                                                                    1 (2%)                                
      Duct, Metaplasia, Squamous                      10 (17%)     14 (24%)      4 (7%)       8 (14%)                               
   Stomach, Forestomach                               (60)         (60)         (59)         (59)                                   
      Erosion                                                                    1 (2%)                                             
      Hyperkeratosis                                   1 (2%)                    1 (2%)       5 (8%)                                
      Hyperplasia, Basal Cell                          2 (3%)       5 (8%)      10 (17%)     20 (34%)                               
      Hyperplasia, Basal Cell, Diffuse                              1 (2%)                    1 (2%)                                
      Hyperplasia, Basal Cell, Focal                   2 (3%)       1 (2%)       2 (3%)       2 (3%)                                
      Hyperplasia, Diffuse, Squamous                                                          1 (2%)                                
      Inflammation, Acute                                                                     3 (5%)                                
      Mineralization, Focal                                                                   1 (2%)                                
      Ulcer                                            4 (7%)       1 (2%)                    2 (3%)                                
   Stomach, Glandular                                 (60)         (58)         (59)         (57)                                   
      Erosion                                          6 (10%)      3 (5%)       7 (12%)      5 (9%)                                
      Hyperplasia, Lymphoid                                                      5 (8%)                                             
      Inflammation, Chronic Active                     2 (3%)       1 (2%)                                                          
      Mineralization                                   1 (2%)                    6 (10%)      2 (4%)                                
   Tongue                                             (2)                       (1)                                                 
      Hemorrhage, Focal                                                          1 (100%)                                           
   Tooth                                                                        (1)                                                 
      Inflammation, Chronic Active                                               1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05145-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            TRICAPRYLIN                                        Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 20:47:57  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (60)         (60)         (59)         (58)                                   
      Cardiomyopathy                                  53 (88%)     53 (88%)     54 (92%)     49 (84%)                               
      Infiltration Cellular, Histiocyte                                          1 (2%)                                             
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Thrombosis                                       5 (8%)       7 (12%)      4 (7%)       2 (3%)                                
      Atrium, Dilatation                               1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (60)         (59)         (59)         (58)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Hypertrophy                                                                1 (2%)       1 (2%)                                
      Hypoplasia                                       1 (2%)                                                                       
      Vacuolization Cytoplasmic                                     1 (2%)                                                          
      Vacuolization Cytoplasmic, Diffuse                                                      1 (2%)                                
   Adrenal Medulla                                    (60)         (59)         (59)         (58)                                   
      Hyperplasia                                     22 (37%)     20 (34%)     22 (37%)     18 (31%)                               
   Islets, Pancreatic                                 (59)         (58)         (59)         (56)                                   
      Hyperplasia                                      7 (12%)      5 (9%)       3 (5%)       1 (2%)                                
   Parathyroid Gland                                  (50)         (56)         (57)         (53)                                   
      Cyst                                                                                    1 (2%)                                
      Hyperplasia                                                   1 (2%)                    1 (2%)                                
   Pituitary Gland                                    (60)         (57)         (59)         (58)                                   
      Pars Distalis, Angiectasis                       3 (5%)       1 (2%)       3 (5%)       2 (3%)                                
      Pars Distalis, Congestion                                     1 (2%)                                                          
      Pars Distalis, Cyst                              2 (3%)       2 (4%)       2 (3%)       4 (7%)                                
      Pars Distalis, Hyperplasia                      11 (18%)     11 (19%)     10 (17%)      6 (10%)                               
      Pars Distalis, Vacuolization Cytoplasmic                                   1 (2%)                                             
      Pars Intermedia, Cyst                                         1 (2%)       1 (2%)                                             
      Pars Intermedia, Hyperplasia                                               1 (2%)                                             
   Thyroid Gland                                      (57)         (56)         (59)         (54)                                   
      Fibrosis                                                      1 (2%)                                                          
      C-Cell, Hyperplasia                              7 (12%)      6 (11%)      9 (15%)      3 (6%)                                
      Follicle, Cyst                                   1 (2%)                                                                       
      Follicular Cell, Hyperplasia                                  2 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05145-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            TRICAPRYLIN                                        Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 20:47:57  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Preputial Gland                                    (59)         (58)         (60)         (58)                                   
      Abscess                                          3 (5%)       4 (7%)       6 (10%)      3 (5%)                                
      Cyst                                                                                    1 (2%)                                
      Dilatation                                                    2 (3%)       1 (2%)       2 (3%)                                
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation, Acute                                           1 (2%)                                                          
      Inflammation, Chronic Active                     2 (3%)                    1 (2%)                                             
      Necrosis                                                      1 (2%)                                                          
   Prostate                                           (59)         (59)         (59)         (59)                                   
      Hyperplasia                                      3 (5%)       9 (15%)      6 (10%)      7 (12%)                               
      Inflammation, Acute                              1 (2%)       1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)       1 (2%)                                                          
   Seminal Vesicle                                    (59)         (60)         (60)         (59)                                   
      Concretion                                                    1 (2%)                                                          
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation, Acute                              1 (2%)                                                                       
   Testes                                             (59)         (60)         (60)         (59)                                   
      Interstitial Cell, Hyperplasia                   6 (10%)      8 (13%)      7 (12%)     10 (17%)                               
      Seminiferous Tubule, Atrophy                     6 (10%)      6 (10%)      1 (2%)       3 (5%)                                
      Seminiferous Tubule, Giant Cell                                                         1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                         (25)         (25)         (25)         (16)                                   
      Lymphatic, Ectasia                                            1 (4%)                                                          
      Mediastinal, Angiectasis                         3 (12%)      2 (8%)       3 (12%)      9 (56%)                               
      Mediastinal, Congestion                                       1 (4%)                                                          
      Mediastinal, Ectasia                                                       5 (20%)                                            
      Mediastinal, Hyperplasia                                      1 (4%)                                                          
      Mediastinal, Hyperplasia, Lymphoid                            1 (4%)                                                          
      Mediastinal, Infiltration Cellular, Mast Cell    1 (4%)                    2 (8%)                                             
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                                2 (8%)                                                          
      Mediastinal, Pigmentation                        3 (12%)      2 (8%)       3 (12%)      1 (6%)                                
      Mediastinal, Lymphatic, Ectasia                               1 (4%)                                                          
      Pancreatic, Angiectasis                                                    1 (4%)       1 (6%)                                
      Pancreatic, Ectasia                                           1 (4%)       1 (4%)       1 (6%)                                
      Pancreatic, Hyperplasia, Lymphoid                2 (8%)       2 (8%)                    1 (6%)                                
      Pancreatic, Infiltration Cellular, Histiocyte    1 (4%)                                                                       
      Pancreatic, Pigmentation                                                   1 (4%)                                             
      Pancreatic, Lymphatic, Ectasia                   1 (4%)       2 (8%)                                                          
      Renal, Pigmentation                                                        1 (4%)                                             
   Lymph Node, Mandibular                             (59)         (56)         (59)         (57)                                   
      Angiectasis                                      1 (2%)       1 (2%)                                                          
      Ectasia                                          1 (2%)                    2 (3%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05145-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            TRICAPRYLIN                                        Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 20:47:57  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Hyperplasia, Lymphoid                                                      2 (3%)                                             
      Infiltration Cellular, Plasma Cell                            2 (4%)                                                          
      Infiltration Cellular, Histiocyte                             1 (2%)                                                          
   Lymph Node, Mesenteric                             (58)         (59)         (60)         (55)                                   
      Angiectasis                                      2 (3%)                    1 (2%)       2 (4%)                                
      Ectasia                                          4 (7%)       2 (3%)       2 (3%)       1 (2%)                                
      Hyperplasia, Lymphoid                                                      2 (3%)                                             
      Infiltration Cellular, Histiocyte                             3 (5%)                                                          
      Lymphatic, Ectasia                                            1 (2%)                    1 (2%)                                
   Spleen                                             (59)         (60)         (59)         (58)                                   
      Angiectasis                                                   1 (2%)                                                          
      Depletion Lymphoid                                            1 (2%)       1 (2%)       3 (5%)                                
      Developmental Malformation                       1 (2%)       1 (2%)                    1 (2%)                                
      Fibrosis                                         8 (14%)     13 (22%)     16 (27%)      9 (16%)                               
      Hematopoietic Cell Proliferation                11 (19%)      9 (15%)     11 (19%)      7 (12%)                               
      Hemorrhage                                                                 1 (2%)                                             
      Infarct                                          2 (3%)                    1 (2%)       1 (2%)                                
      Mineralization                                                             1 (2%)                                             
      Pigmentation                                                                            3 (5%)                                
      Capsule, Fibrosis                                                                       1 (2%)                                
      Lymphoid Follicle, Atrophy                       2 (3%)                                                                       
   Thymus                                             (56)         (55)         (56)         (53)                                   
      Congestion                                       1 (2%)                                                                       
      Cyst                                             1 (2%)                                                                       
      Epithelial Cell, Hyperplasia                                                            1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (51)         (48)         (47)         (47)                                   
      Galactocele                                                                             2 (4%)                                
      Hemorrhage, Focal                                1 (2%)                                                                       
   Skin                                               (59)         (59)         (58)         (59)                                   
      Cyst                                                                                    1 (2%)                                
      Cyst Epithelial Inclusion                        1 (2%)       1 (2%)       1 (2%)                                             
      Developmental Malformation                                    1 (2%)                                                          
      Hyperkeratosis                                   2 (3%)                                 2 (3%)                                
      Inflammation, Chronic Active                                  1 (2%)       1 (2%)                                             
      Ulcer                                                         1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (60)         (60)         (60)         (60)                                   
      Hyperostosis                                     1 (2%)                    1 (2%)                                             
   Skeletal Muscle                                    (50)         (50)         (47)         (53)                                   
      Atrophy                                          3 (6%)       1 (2%)       2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05145-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            TRICAPRYLIN                                        Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 20:47:57  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
MUSCULOSKELETAL SYSTEM - CONT                                                                                                       
      Infiltration Cellular, Histiocyte                1 (2%)                                                                       
      Mineralization                                                                          1 (2%)                                
      Thrombosis                                       1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (60)         (60)         (59)         (60)                                   
      Hemorrhage                                       1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (60)         (60)         (60)         (58)                                   
      Congestion                                       1 (2%)                    1 (2%)                                             
      Edema                                                                      2 (3%)       2 (3%)                                
      Fungus                                           1 (2%)                                                                       
      Hemorrhage                                       2 (3%)       2 (3%)       1 (2%)       1 (2%)                                
      Infiltration Cellular, Histiocyte                1 (2%)       6 (10%)      4 (7%)       4 (7%)                                
      Inflammation, Acute                              1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Inflammation, Chronic Active                                               1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                                           3 (5%)       1 (2%)                                
      Mediastinum, Inflammation                                     1 (2%)                                                          
      Pleura, Inflammation, Chronic Active                          1 (2%)                                                          
   Nose                                               (60)         (59)         (60)         (59)                                   
      Fungus                                          21 (35%)      7 (12%)     12 (20%)      5 (8%)                                
      Hyperkeratosis                                                             1 (2%)       2 (3%)                                
      Inflammation, Acute                             24 (40%)     11 (19%)     15 (25%)      5 (8%)                                
      Respiratory Epithelium, Hyperplasia                           1 (2%)       3 (5%)                                             
      Respiratory Epithelium, Metaplasia, Squamous     9 (15%)                   3 (5%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)                       (1)          (3)                                    
      Hemorrhage                                                                              1 (33%)                               
      Necrosis                                                                                2 (67%)                               
      Lens, Cataract                                                             1 (100%)     1 (33%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)         (60)         (60)         (56)                                   
      Cyst                                             2 (3%)       1 (2%)       2 (3%)       1 (2%)                                
      Hydronephrosis                                                             1 (2%)                                             
      Infarct                                                                    1 (2%)                                             
      Nephropathy                                     56 (93%)     51 (85%)     50 (83%)     31 (55%)                               
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05145-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            TRICAPRYLIN                                        Date: 09/17/94  
Route: GAVAGE                                                                                                     Time: 20:47:57  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 ML/KG      2.5 MLKG     5.0 MLKG     10.0                                      
                                                                                          ML/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Cortex, Mineralization                           2 (3%)                                                                       
      Renal Tubule, Hyperplasia                                                  1 (2%)                                             
      Transitional Epithelium, Hyperplasia             2 (3%)                                                                       
   Urinary Bladder                                    (58)         (57)         (58)         (55)                                   
      Calculus Gross Observation                                    3 (5%)                                                          
      Calculus Micro Observation Only                               3 (5%)                    1 (2%)                                
      Hemorrhage                                       1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------